Prevalence of hypertension in renal disease (original) (raw)

Journal Article

,

Hospital General Universitario Gregorio Marañón, Madrid, Spain

Search for other works by this author on:

,

Hospital General Universitario Gregorio Marañón, Madrid, Spain

Search for other works by this author on:

,

Soledad García de Vinuesa

Hospital General Universitario Gregorio Marañón, Madrid, Spain

Search for other works by this author on:

,

Hospital General Universitario Gregorio Marañón, Madrid, Spain

Search for other works by this author on:

,

Hospital General Universitario Gregorio Marañón, Madrid, Spain

Search for other works by this author on:

Hospital General Universitario Gregorio Marañón, Madrid, Spain

Search for other works by this author on:

Cite

Natalia Ridao, José Luño, Soledad García de Vinuesa, Francisco Gómez, Alberto Tejedor, Fernando Valderrábano, Prevalence of hypertension in renal disease, Nephrology Dialysis Transplantation, Volume 16, Issue suppl_1, May 2001, Pages 70–73, https://doi.org/10.1093/ndt/16.suppl_1.70
Close

Navbar Search Filter Mobile Enter search term Search

Abstract

Background. Hypertension (HTN) is very frequent in patients with renal disease and its prevalence increases as renal failure progresses.

Methods. We studied the prevalence of HTN in 1921 patients with different nephropathies. Patients on dialysis and renal transplant patients were not included in the study. HTN was defined as SBP>140 and/or DBP>90 mmHg, or requiring antihypertensive therapy.

Results. The prevalence of HTN in the total group of patients with renal diseases was 60.5%, but this prevalence varied widely depending upon the type of underlying nephropathy. The prevalence of HTN was practically universal in patients with renal vascular disease (93%) and in patients with established diabetic nephropathy (87%), and 74% of the patients with polycystic kidney disease, 63% of the patients with chronic pyelonephritis and 54% of the patients diagnosed with glomerulonephritis were hypertensive. The prevalence of HTN in patients with renal insufficiency (80%) is significantly higher than that in patients without renal insufficiency (43% P<0.001). In a multiple logistic regression analysis, the independent risk factors defining HTN in renal patients were: renal failure, age, the presence of diabetes, hypertriglyceridaemia and proteinuria. Antihypertensive treatment consisted of diet alone in 4% of the patients, one drug in 45%, two drugs in 36%, three medications in 13% and more than three drugs in 2.5%. The angiotensin‐converting enzyme (ACE) inhibitors were the most frequently prescribed drug (39% of the patients treated in monotherapy) followed by calcium channel blockers (27%), diuretics (18%) and _β_‐blockers (9%). The most common combined therapy was a diuretic plus an ACE inhibitor. The percentage of patients with BP controlled according to current recommendations for renal patients (BP<130/85) was very low; SBP in only 49% and DBP in 24%. Control of both was only achieved in 10% of the patients.

Conclusions. There is a high prevalence of HTN in renal patients, which depends on the type of nephropathy and the degree of renal failure. Other independent risk factors for HTN in patients with renal disease are: advanced age, the presence of diabetes, hypertriglyceridaemia and the severity of proteinuria. BP control in renal patients is quite poor and should be improved to reduce progression of the renal disease.

This content is only available as a PDF.

© European Renal Association-European Dialysis and Transplant Association

Topic:

You do not currently have access to this article.

I agree to the terms and conditions. You must accept the terms and conditions.

Submit a comment

Name

Affiliations

Comment title

Comment

You have entered an invalid code

Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.

Personal account

Get help with access

Institutional access

Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:

IP based access

Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.

Sign in through your institution

Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.

  1. Click Sign in through your institution.
  2. Select your institution from the list provided, which will take you to your institution's website to sign in.
  3. When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
  4. Following successful sign in, you will be returned to Oxford Academic.

If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.

Sign in with a library card

Enter your library card number to sign in. If you cannot sign in, please contact your librarian.

Society Members

Society member access to a journal is achieved in one of the following ways:

Sign in through society site

Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:

  1. Click Sign in through society site.
  2. When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
  3. Following successful sign in, you will be returned to Oxford Academic.

If you do not have a society account or have forgotten your username or password, please contact your society.

Sign in using a personal account

Some societies use Oxford Academic personal accounts to provide access to their members. See below.

Personal account

A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Some societies use Oxford Academic personal accounts to provide access to their members.

Viewing your signed in accounts

Click the account icon in the top right to:

Signed in but can't access content

Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.

Institutional account management

For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.

Purchase

Short-term Access

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

Prevalence of hypertension in renal disease - 24 Hours access

EUR €39.00

GBP £34.00

USD $42.00

Rental

Read this now at DeepDyve

This article is also available for rental through DeepDyve.

Advertisement intended for healthcare professionals

Citations

Views

Altmetric

Metrics

Total Views 1,424

146 Pageviews

1,278 PDF Downloads

Since 1/1/2017

Month: Total Views:
January 2017 8
February 2017 3
March 2017 1
April 2017 3
May 2017 1
June 2017 4
July 2017 3
August 2017 5
September 2017 3
October 2017 11
November 2017 1
December 2017 46
January 2018 24
February 2018 29
March 2018 17
April 2018 34
May 2018 5
June 2018 3
July 2018 6
August 2018 3
September 2018 4
October 2018 2
November 2018 1
December 2018 4
January 2019 7
February 2019 4
March 2019 8
April 2019 14
May 2019 10
June 2019 12
July 2019 12
August 2019 11
September 2019 11
October 2019 12
November 2019 12
December 2019 15
January 2020 7
February 2020 8
March 2020 17
April 2020 19
May 2020 6
June 2020 15
July 2020 16
August 2020 16
September 2020 20
October 2020 22
November 2020 6
December 2020 13
January 2021 7
February 2021 13
March 2021 13
April 2021 13
May 2021 18
June 2021 14
July 2021 17
August 2021 18
September 2021 24
October 2021 16
November 2021 23
December 2021 17
January 2022 14
February 2022 29
March 2022 39
April 2022 30
May 2022 22
June 2022 25
July 2022 13
August 2022 8
September 2022 12
October 2022 26
November 2022 25
December 2022 16
January 2023 22
February 2023 24
March 2023 16
April 2023 20
May 2023 19
June 2023 21
July 2023 17
August 2023 19
September 2023 15
October 2023 24
November 2023 23
December 2023 18
January 2024 21
February 2024 21
March 2024 30
April 2024 37
May 2024 18
June 2024 36
July 2024 20
August 2024 18
September 2024 15
October 2024 1
November 2024 3

Citations

67 Web of Science

×

Email alerts

Citing articles via

More from Oxford Academic

Advertisement intended for healthcare professionals